FACIAL DYSMORPHISM

FACIAL DYSMORPHISM was reported 221 times

FACIAL DYSMORPHISM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 beta Lactamase Inhibitor [EPC] 2 0.0004
1 Anthelmintic [EPC] 1 0.0003
2 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 6 0.0002
3 Prostaglandin E1 Analog [EPC] 3 0.0002
4 Mood Stabilizer [EPC] 39 0.0002
5 Nitrofuran Antibacterial [EPC] 3 0.0002
6 Anti-epileptic Agent [EPC] 27 0.0001
7 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
8 Azole Antifungal [EPC] 8 0.0001
9 Recombinant Human Growth Hormone [EPC] 1 0.0000
10 Protease Inhibitor [EPC] 2 0.0000
11 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
12 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1 0.0000
13 Phenothiazine [EPC] 1 0.0000
14 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
15 Retinoid [EPC] 8 0.0000
16 Benzodiazepine [EPC] 22 0.0000
17 Vitamin D [EPC] 9 0.0000
18 Vitamin B12 [EPC] 9 0.0000
19 Folate Analog Metabolic Inhibitor [EPC] 12 0.0000
20 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
21 Vitamin C [EPC] 9 0.0000
22 Alkylating Drug [EPC] 5 0.0000
23 Purine Antimetabolite [EPC] 2 0.0000
24 Aminosalicylate [EPC] 2 0.0000
25 Nucleoside Metabolic Inhibitor [EPC] 5 0.0000
26 Nitroimidazole Antimicrobial [EPC] 1 0.0000
27 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
28 Atypical Antipsychotic [EPC] 5 0.0000
29 Acetylcholine Release Inhibitor [EPC] 1 0.0000
30 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
31 Platinum-based Drug [EPC] 2 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 9 0.0000
33 Thiazide Diuretic [EPC] 1 0.0000
34 Corticosteroid [EPC] 6 0.0000
35 Opioid Agonist [EPC] 1 0.0000
36 Progestin [EPC] 1 0.0000
37 beta-Adrenergic Blocker [EPC] 1 0.0000
38 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
39 Insulin Analog [EPC] 1 0.0000